The New Jersey Department of Health and Senior Services has granted a license to the newest stem cell collection center of the NeoStem network at the Giampapa Institute for Anti-Aging medical Therapy to open and maintain operations in the city, and file a a patent application for one of its innovative anti-aging treatments.
According to a recent press release, the director of the Giampapa Institute for Anti-Aging medical Therapy, one of the first anti-aging medical physicians in the world, has developed an innovative facial rejuvenation procedure that involves using stem cells to restore the skin and get rid of wrinkles.
The Stem Cell Face Lift would involve injecting plurpotent cells and stem cells, the types of cells that are directly involved with cell regrowth and regeneration, directly into the skin to increase their firmness and enhance the skin’s texture. The pluripotent cells would be responsible for stimulating the growth of skin cells and thereby reducing the prevalence of wrinkles.
This facelift procedure would not involve any major incisions or surgery, and could be performed under local anesthesia. Unlike the traditional facelift that involves manipulating the facial tissues and reshaping the face, this facelift procedure would involve an ‘inside out’ approach where the stem cells would get to work right away. Most patients would only need about a week of recovery time, and may even be able to enhance results with a combination of dermal fillers such as Restylane and Botox.
NeoStem is currently the pioneer in collecting adult stem cells and has developed a network of adult stem cell collection centers where people can donate and share stem cells for personal use. The company is working on getting a patent for this procedure, because it uses proprietary stem cell technology, and has several benefits for cosmetic facial rejuvenation.